Jun 22, 2026 09:00AM

Jun 11, 2026 09:02AM

Jun 11, 2026 09:00AM

Jun 9, 2026 09:01AM

Jun 9, 2026 09:00AM

Apr 6, 2026 09:20AM

Apr 6, 2026 09:20AM NeuroSense Granted Brazilian Patent Covering PrimeC Composition

Mar 31, 2026 09:20AM

Mar 24, 2026 09:03AM

Mar 24, 2026 09:00AM

Mar 18, 2026 08:00AM

Mar 16, 2026 11:34AM

Mar 16, 2026 11:33AM

Mar 9, 2026 11:07AM PrimeC Long-Term Survival Data to Be Presented at a Leading ALS Scientific Conference

Feb 18, 2026 09:05AM

Feb 18, 2026 09:05AM

Feb 9, 2026 09:20AM

Feb 9, 2026 09:20AM

Jan 21, 2026 08:30AM

Jan 21, 2026 08:30AM

Jan 8, 2026 08:45AM World-Renowned Alzheimer's Expert Prof. Steven Arnold Joins NeuroSense SAB

Dec 22, 2025 09:18AM

Dec 22, 2025 09:17AM

Dec 4, 2025 07:30AM

Nov 24, 2025 09:56AM

Nov 24, 2025 09:56AM

Oct 6, 2025 09:00AM

Sep 10, 2025 02:30PM NeuroSense's Drug Candidate Shows Early Signals of Benefit in Alzheimer's Patient-Derived Neurons

Sep 4, 2025 08:49AM

Sep 4, 2025 08:49AM

Aug 1, 2025 09:00AM

Jul 22, 2025 08:42AM

Apr 24, 2025 09:09AM

Apr 24, 2025 09:09AM

Apr 9, 2025 08:30AM Neurosense Therapeutics (NRSN) Announces Transformative Phase 2b MicroRNA Data

Apr 9, 2025 08:30AM

Apr 7, 2025 05:14PM

Apr 4, 2025 09:10AM

Mar 20, 2025 10:30AM

Mar 17, 2025 08:30AM

Jan 6, 2025 09:02AM

Jan 6, 2025 09:00AM NeuroSense Regains Compliance with Nasdaq's Minimum Equity Requirement

Dec 23, 2024 09:00AM

Dec 18, 2024 10:25AM

Dec 11, 2024 09:25AM

Dec 11, 2024 09:25AM

Dec 4, 2024 08:30AM

Dec 2, 2024 08:32AM

Dec 2, 2024 08:30AM NeuroSense Therapeutics Announces $5 Million Private Placement at Premium to Market Price

Nov 21, 2024 09:20AM

323,981 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All